Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.31 USD | -1.77% | +0.53% | -11.27% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 93.99M | Sales 2025 * | 149M | Capitalization | 481M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -108M | EV / Sales 2024 * | 4.17 x |
Net cash position 2024 * | 88.52M | Net cash position 2025 * | 308M | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
-3.69
x | P/E ratio 2025 * |
-4.53
x | Employees | 204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.16% |
Latest transcript on UroGen Pharma Ltd.
1 day | -1.77% | ||
1 week | +0.53% | ||
Current month | +0.08% | ||
1 month | -6.66% | ||
3 months | -25.10% | ||
6 months | +2.15% | ||
Current year | -11.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 19-01-02 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 21-07-31 |
Jason Smith
CMP | Compliance Officer | 52 | 20-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 12-09-30 |
Cynthia Butitta
BRD | Director/Board Member | 69 | 17-09-30 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 13.3 | -1.85% | 112,219 |
24-05-30 | 13.55 | +2.19% | 332,164 |
24-05-29 | 13.26 | -2.57% | 377,788 |
24-05-28 | 13.61 | +2.79% | 300,931 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.27% | 481M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- URGN Stock